| Mrs Emily Rose Claude, MS, APRN, FNP-C | |
|
295 Varnum Ave, Lowell, MA 01854-2134 | |
| (978) 397-6000 | |
| Not Available |
| Full Name | Mrs Emily Rose Claude |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 295 Varnum Ave, Lowell, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720686108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | RN2294682 (Massachusetts) | Secondary |
| 363L00000X | Nurse Practitioner | RN2294682 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Emily Rose Claude, MS, APRN, FNP-C 10 Rita Ave, Hudson, NH 03051-5029 Ph: (603) 560-3615 | Mrs Emily Rose Claude, MS, APRN, FNP-C 295 Varnum Ave, Lowell, MA 01854-2134 Ph: (978) 397-6000 |
News Archive
"Health care may be a costly drag on the economy, but it's still a great place to find a job," The New York Times reports. "Midcareer managers and other workers have been migrating to health care jobs for years, of course. Now, with the recession, the lure is even stronger. Hospitals, which employ more than four million people, added 135,000 jobs last year and 19,400 more in the first half of 2009, even as millions of American workers wound up unemployed." For many working in the field, health care is a second career. "Many managers with experience in fields like human resources, finance and marketing find a welcome in health care, with a little studying up."
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
Scientists in this week's Christmas issue of the BMJ have discovered the 'Polymeal', a set of ingredients which cuts the risk of heart (cardiovascular) disease by 76% and significantly increases life expectancy.
In a new study published today in JAMA Pediatrics (formerly Archives of Pediatrics and Adolescent Medicine), Kaiser Permanente researchers found that 49 percent of children ages 2-24 months did not receive all recommended vaccinations or did not get vaccinated according to the Advisory Committee on Immunization Practices schedule.
› Verified 9 days ago